Free Trial

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $15.79 Million Position in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background
Remove Ads

Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 2.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 173,721 shares of the company's stock after selling 4,151 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS's holdings in Colgate-Palmolive were worth $15,793,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. iA Global Asset Management Inc. grew its stake in shares of Colgate-Palmolive by 16.7% during the 4th quarter. iA Global Asset Management Inc. now owns 52,930 shares of the company's stock worth $4,812,000 after acquiring an additional 7,592 shares in the last quarter. Fiduciary Group LLC boosted its holdings in Colgate-Palmolive by 38.5% during the fourth quarter. Fiduciary Group LLC now owns 12,043 shares of the company's stock worth $1,095,000 after purchasing an additional 3,345 shares during the last quarter. Teacher Retirement System of Texas grew its position in Colgate-Palmolive by 23.9% in the fourth quarter. Teacher Retirement System of Texas now owns 1,041,938 shares of the company's stock valued at $94,723,000 after purchasing an additional 201,274 shares in the last quarter. Atlantic Private Wealth LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $159,000. Finally, Royal London Asset Management Ltd. lifted its position in Colgate-Palmolive by 1.8% during the 4th quarter. Royal London Asset Management Ltd. now owns 453,820 shares of the company's stock worth $41,257,000 after buying an additional 8,197 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

CL has been the subject of several analyst reports. Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Raymond James restated an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reissued a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $101.72.

View Our Latest Stock Report on CL

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded down $1.38 during trading on Tuesday, reaching $89.52. 5,173,007 shares of the stock were exchanged, compared to its average volume of 4,226,853. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The stock has a 50-day moving average price of $89.40 and a 200-day moving average price of $93.95. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market cap of $72.65 billion, a PE ratio of 25.43, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm posted $0.87 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive announced that its board has initiated a share buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.32%. Colgate-Palmolive's dividend payout ratio is 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads